• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Cronos Group Inc.

    6/2/25 8:36:56 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CRON alert in real time by email
    SD 1 formsd-fy2024.htm SD Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM SD
    Specialized Disclosure Report

    CRONOS GROUP INC.
    (Exact name of the registrant as specified in its charter)

    British Columbia, Canada001-38403N/A
    (State or other jurisdiction
    of incorporation)
    (Commission File Number)(I.R.S. Employer
    Identification No.)

    4491 Concession Rd 12
    Stayner, Ontario
    L0M 1S0
    (Address of principal executive offices)(Zip Code)


    Terry Doucet
    General Counsel and Corporate Secretary        
    (416) 504-0004
    (Name and telephone number, including area code,
    of the person to contact in connection with this report.)

    Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:


    xRule 13p‑1 under the Securities Exchange Act (17 CFR 240.13p‑1) for the reporting period from January 1 to December 31, 2023.
    oRule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended December 31, 2023.








    Section 1 - Conflict Minerals Disclosure

    Item 1.01    Conflict Minerals Disclosure and Report

    A copy of the Conflict Minerals Report of Cronos Group Inc. (“Cronos”) is provided as Exhibit 1.01 to this Form SD and is publicly available at https://thecronosgroup.gcs-web.com/financial-information/sec-filings. The information contained in, and that can be accessed through, the respective websites of Cronos and its subsidiaries is not, and shall not be deemed to be, a part of this Form SD or its Conflict Minerals Report or incorporated into any other filings Cronos makes with the Securities and Exchange Commission.

    Item 1.02      Exhibit

    A copy of Cronos’ Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD.

    Section 2 - Exhibits

    Item 2.01      Exhibits

    Exhibit 1.01      Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.








    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

    Date: June 1, 2025
    CRONOS GROUP INC.
    By:/s/ Mike Gorenstein
    Name:
    Mike Gorenstein
    Title:
    Chairman, President and Chief Executive Officer





    Get the next $CRON alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CRON

    DatePrice TargetRatingAnalyst
    11/2/2022$3.00Mkt Perform
    Bernstein
    7/28/2022Hold → Buy
    Canaccord Genuity
    5/11/2022Neutral → Sector Outperform
    CIBC
    3/22/2022Underweight → Equal Weight
    Barclays
    3/7/2022$4.00 → $3.00Neutral
    Piper Sandler
    2/22/2022$7.00 → $4.25Sell
    Canaccord Genuity
    2/22/2022$7.00 → $4.00Neutral
    Piper Sandler
    1/27/2022$5.54 → $3.24Underperform → Hold
    Jefferies
    More analyst ratings

    $CRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Doucet Terrence Gregory Joseph converted options into 12,876 shares and covered exercise/tax liability with 6,266 shares, increasing direct ownership by 10% to 70,141 units (SEC Form 4)

      4 - Cronos Group Inc. (0001656472) (Issuer)

      5/13/25 6:36:28 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Officer Weigensberg Arye converted options into 12,132 shares, increasing direct ownership by 10% to 129,469 units (SEC Form 4)

      4 - Cronos Group Inc. (0001656472) (Issuer)

      5/13/25 6:35:37 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 4 filed by Officer Buggy Shannon

      4 - Cronos Group Inc. (0001656472) (Issuer)

      5/13/25 6:34:30 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care